Bruce Caswell Acquires 3,500 Shares of Maximus, Inc. (NYSE:MMS) Stock

Maximus, Inc. (NYSE:MMS - Get Free Report) CEO Bruce Caswell purchased 3,500 shares of Maximus stock in a transaction dated Tuesday, December 17th. The shares were purchased at an average cost of $70.64 per share, for a total transaction of $247,240.00. Following the completion of the transaction, the chief executive officer now owns 275,929 shares of the company's stock, valued at approximately $19,491,624.56. This represents a 1.28 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Maximus Stock Down 0.2 %

MMS stock traded down $0.13 during mid-day trading on Wednesday, hitting $70.07. 1,073,975 shares of the company were exchanged, compared to its average volume of 438,459. The firm has a market cap of $4.22 billion, a P/E ratio of 14.01 and a beta of 0.73. Maximus, Inc. has a 1-year low of $69.72 and a 1-year high of $93.97. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.49 and a current ratio of 1.49. The firm's 50 day simple moving average is $81.37 and its 200 day simple moving average is $86.30.

Maximus Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Saturday, November 30th. Investors of record on Friday, November 15th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.71%. The ex-dividend date of this dividend was Friday, November 15th. Maximus's payout ratio is presently 24.00%.

Institutional Trading of Maximus

A number of institutional investors have recently modified their holdings of the company. Healthcare of Ontario Pension Plan Trust Fund grew its stake in shares of Maximus by 942.9% in the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 323,300 shares of the health services provider's stock valued at $27,707,000 after buying an additional 292,300 shares in the last quarter. Versor Investments LP raised its stake in Maximus by 213.5% in the third quarter. Versor Investments LP now owns 8,500 shares of the health services provider's stock valued at $792,000 after buying an additional 5,789 shares during the period. Charles Schwab Investment Management Inc. lifted its stake in shares of Maximus by 12.4% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 929,066 shares of the health services provider's stock worth $86,552,000 after buying an additional 102,350 shares during the last quarter. Citigroup Inc. boosted its holdings in shares of Maximus by 143.3% during the third quarter. Citigroup Inc. now owns 59,448 shares of the health services provider's stock worth $5,538,000 after acquiring an additional 35,012 shares during the period. Finally, Algert Global LLC bought a new stake in Maximus in the 2nd quarter valued at $12,424,000. 97.21% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, StockNews.com lowered Maximus from a "buy" rating to a "hold" rating in a report on Thursday, November 28th.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.